Latest Insider Transactions at Centessa Pharmaceuticals PLC (CNTA)
This section provides a real-time view of insider transactions for Centessa Pharmaceuticals PLC (CNTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Centessa Pharmaceuticals plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Centessa Pharmaceuticals plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 04
2023
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
6,970
-0.92%
|
$20,910
$3.18 P/Share
|
|
Dec 31
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
2,268
-0.3%
|
$6,804
$3.1 P/Share
|
|
Dec 31
2022
|
David J Grainger Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,497
-0.27%
|
$7,491
$3.1 P/Share
|
|
Dec 31
2022
|
Iqbal J Hussain General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,996
-2.45%
|
$11,988
$3.1 P/Share
|
|
Dec 31
2022
|
Saurabh Saha Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
44,025
-5.87%
|
$132,075
$3.1 P/Share
|
|
Dec 31
2022
|
Thomas Templeman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,921
-2.08%
|
$8,763
$3.1 P/Share
|
|
Dec 31
2022
|
Gregory M Weinhoff Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,303
-2.21%
|
$15,909
$3.1 P/Share
|
|
Dec 31
2022
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
3,014
-2.15%
|
$9,042
$3.1 P/Share
|
|
Dec 31
2022
|
David M Chao Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,889
-2.12%
|
$14,667
$3.1 P/Share
|
|
Dec 01
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
9,400
-1.22%
|
$28,200
$3.91 P/Share
|
|
Nov 01
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
9,700
-1.25%
|
$38,800
$4.03 P/Share
|
|
Oct 03
2022
|
Thomas Templeman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,455
-1.78%
|
$7,365
$3.95 P/Share
|
|
Oct 03
2022
|
David J Grainger Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
2,853
-0.31%
|
$8,559
$3.95 P/Share
|
|
Oct 03
2022
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,901
-2.08%
|
$14,703
$3.95 P/Share
|
|
Oct 03
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
12,524
-1.59%
|
$37,572
$3.92 P/Share
|
|
Oct 03
2022
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
4,563
-2.86%
|
$13,689
$3.95 P/Share
|
|
Oct 03
2022
|
Javad Shahidi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,341
-2.06%
|
$10,023
$3.95 P/Share
|
|
Oct 03
2022
|
David M Chao Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
4,167
-1.83%
|
$12,501
$3.95 P/Share
|
|
Oct 03
2022
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
2,595
-1.88%
|
$7,785
$3.95 P/Share
|
|
Sep 30
2022
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
5,765
-4.12%
|
$23,060
$4.25 P/Share
|
|
Sep 30
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,732
-0.98%
|
$30,928
$4.25 P/Share
|
|
Sep 30
2022
|
Gregory M Weinhoff Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,282
-4.7%
|
$45,128
$4.25 P/Share
|
|
Sep 30
2022
|
Iqbal J Hussain General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,445
-7.02%
|
$45,780
$4.25 P/Share
|
|
Sep 30
2022
|
David M Chao Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,211
-4.0%
|
$36,844
$4.25 P/Share
|
|
Sep 30
2022
|
David J Grainger Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,154
-0.78%
|
$28,616
$4.25 P/Share
|
|
Sep 30
2022
|
Thomas Templeman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,382
-3.84%
|
$21,528
$4.25 P/Share
|
|
Sep 30
2022
|
Thomas Templeman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,003
-1.43%
|
$8,012
$4.07 P/Share
|
|
Sep 30
2022
|
David J Grainger Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
2,328
-0.25%
|
$9,312
$4.07 P/Share
|
|
Sep 30
2022
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.67%
|
$16,000
$4.07 P/Share
|
|
Sep 30
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
2,468
-0.31%
|
$9,872
$4.07 P/Share
|
|
Sep 30
2022
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
3,725
-2.29%
|
$14,900
$4.07 P/Share
|
|
Sep 30
2022
|
Javad Shahidi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,727
-1.65%
|
$10,908
$4.07 P/Share
|
|
Sep 30
2022
|
David M Chao Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
3,401
-1.48%
|
$13,604
$4.07 P/Share
|
|
Sep 30
2022
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
2,118
-1.51%
|
$8,472
$4.07 P/Share
|
|
Sep 01
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
10,423
-1.3%
|
$41,692
$4.41 P/Share
|
|
Aug 01
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
10,423
-1.29%
|
$41,692
$4.45 P/Share
|
|
Jul 18
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
20,000
-2.41%
|
$80,000
$4.87 P/Share
|
|
Jul 01
2022
|
Antoine Yver EVP & Chairman of Development |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+10.75%
|
-
|
|
Jul 01
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
9,100
-1.23%
|
$45,500
$5.03 P/Share
|
|
Jul 01
2022
|
Saurabh Saha Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+50.0%
|
-
|
|
Jul 01
2022
|
Gregory M Weinhoff Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
230,000
+48.94%
|
-
|
|
Jul 01
2022
|
David J Grainger Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+9.86%
|
-
|
|
Jul 01
2022
|
Javad Shahidi Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
165,000
+50.0%
|
-
|
|
Jul 01
2022
|
Thomas Templeman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+49.96%
|
-
|
|
Jul 01
2022
|
Iqbal J Hussain General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+49.54%
|
-
|
|
Jul 01
2022
|
David M Chao Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
230,000
+49.95%
|
-
|
|
Jul 01
2022
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+50.0%
|
-
|
|
Jun 24
2022
|
Saurabh Saha Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+20.83%
|
$40,000
$4.63 P/Share
|
|
Jun 17
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
9,200
-1.23%
|
$36,800
$4.68 P/Share
|
|
May 18
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
64,778
-7.96%
|
$323,890
$5.1 P/Share
|